DB-Retard
Brand names,
DB-Retard
Analogs
DB-Retard
Brand Names Mixture
DB-Retard
Chemical_Formula
C10H15N5
DB-Retard
RX_link
No information avaliable
DB-Retard
fda sheet
DB-Retard
msds (material safety sheet)
DB-Retard
Synthesis Reference
Shapiro, Freedman, U.S. pats. 2,961,377, 3,057,780 (1960, 1962 both to U.S.V.)
DB-Retard
Molecular Weight
205.26 g/mol
DB-Retard
Melting Point
175-178 oC
DB-Retard
H2O Solubility
210 mg/mL
DB-Retard
State
Solid
DB-Retard
LogP
0.759
DB-Retard
Dosage Forms
No information avaliable
DB-Retard
Indication
For the reatment of type II diabetes mellitus.
DB-Retard
Pharmacology
Used to treat diabetes, phenformin is a biguanide (contains 2 guanidino groups) hypoglycemic agent with actions and uses similar to those of metformin (Glucophage). Both drugs work by (1) decreasing the absorption of glucose by the intestines, (2) decreasing the production of glucose in the liver, and by (3) increasing the body's ability to use insulin more effectively. More specifically, phenformin improves glycemic control by improving insulin sensitivity. Phenformin is generally considered to be associated with an unacceptably high incidence of actic acidosis. In general biguanides should be used only in stable type II diabetics who are free of liver, kidney and cardiovascular problems and who cannot be controlled with diet.
DB-Retard
Absorption
No information avaliable
DB-Retard
side effects and Toxicity
No information avaliable
DB-Retard
Patient Information
No information avaliable
DB-Retard
Organisms Affected
Humans and other mammals